Motus GI Holdings, Inc. (MOTS)
NASDAQ: MOTS · IEX Real-Time Price · USD
4.00
-0.28 (-6.54%)
Nov 27, 2023, 4:00 PM EST - Market closed
Company Description
Motus GI Holdings, Inc. operates as a medical technology company in the United States.
It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures.
The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.
Motus GI Holdings, Inc.
Country | United States |
IPO Date | Feb 14, 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 43 |
CEO | Mark Pomeranz |
Contact Details
Address: 1301 East Broward Boulevard, 3rd Floor Ft. Lauderdale, Florida 33301 United States | |
Phone | 786-459-1831 |
Website | motusgi.com |
Stock Details
Ticker Symbol | MOTS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001686850 |
CUSIP Number | 62014P108 |
ISIN Number | US62014P5044 |
Employer ID | 81-4042793 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Timothy P. Moran | Chief Executive Officer and Director |
Mark Pomeranz | President, Chief Operating Officer and Director |
Andrew Lawrence Taylor M.B.A. | Chief Financial Officer |
Scott C. Aldrich Jr. | Vice President of Global Marketing and Strategy |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 27, 2023 | 8-K | Current Report |
Nov 13, 2023 | 10-Q | Quarterly Report |
Nov 13, 2023 | 8-K | Current Report |
Nov 2, 2023 | 8-K | Current Report |
Oct 20, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Oct 2, 2023 | 8-K | Current Report |
Sep 22, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Sep 21, 2023 | 8-K | Current Report |
Sep 14, 2023 | 8-K | Current Report |
Sep 7, 2023 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |